The report "Cancer Immunotherapy Market by product type (Oncolytic Viral Therapies & Cancer Vaccines, Monoclonal Antibodies, Immunomodulators), by cancer type (Breast, Lung) - Global Forecasts to 2030"

The global cancer immunotherapy market is projected to reach USD 120 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 14.2% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing adoption of immunotherapy drugs over conventional treatment regimens.

Immuno-oncology, another name for cancer immunotherapy, is a type of treatment that uses the body's immune system to locate, target, and destroy cancer cells. Immunotherapy encourages the body's immune system to identify and combat cancer cells, in contrast to conventional cancer therapies like chemotherapy and radiation therapy, which target cancer cells directly.

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=27333

Competitive Dashboard:
The prominent key players operating in the global Cancer Immunotherapy market are Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Janssen Pharmaceutical, AstraZeneca, Gilead Sciences, Inc., Lilly., Amgen Inc., Novartis AG, GSK plc., Pfizer Inc., Incyte., Celldex Therapeutics, Atara Biotherapeutics, Inc., Cellectis, AbbVie Inc., Bayer AG

Regional Overview:
The report also examines the current concerns and their Future Effects on the Cancer Immunotherapy Market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the Cancer Immunotherapy Market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
• Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
• Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

A Few Points from the Table of Contents –
1. Executive Summary
2. Global Cancer Immunotherapy Market Introduction
3. Global Cancer Immunotherapy Market Dynamics
4. Global Cancer Immunotherapy Market Analysis, 2019 - 2023 and Forecast 2024 – 2030
……………….
9. Global Cancer Immunotherapy Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10. North America Cancer Immunotherapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11. Europe Cancer Immunotherapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12. Asia Pacific (APAC) Cancer Immunotherapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13. Middle East and Africa (MEA) Cancer Immunotherapy Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14. Latin America Cancer Immunotherapy Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15. Competition Landscape
16. Research Methodology
17. Appendix and Abbreviations

Scope of The Report:

• The cancer immunotherapy market research report includes historical data, trending features, and market growth estimates for the future.
• The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
• The cancer immunotherapy market report helps to provide the best results for business enhancement and business growth.
• The report gives a comprehensive overview of both primary and secondary data.
• The cancer immunotherapy market key players are covered here to help them strengthen their place in the market.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747